Fiche société
Dongkook Pharmaceutical Co., Ltd.
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| DKF-MA102A phase 3, multi-center, single-group, open-label study to evaluate the efficacy and safety of DKF-MA102 in patients with prostate cancer. | Cancer | Phase 3 | À vérifier | South Korea | À vérifier |
| DKF-MA102A phase 3, multi-center, single-group, open-label study to evaluate the efficacy and safety of DKF-MA102 in patients with prostate cancer. | Cancer | Phase 3 | À vérifier | South Korea | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| DKF-MA102 | Cancer | Phase 3 | NCT06490328 | Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer | COMPLETED |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||